Source: International Congress 2014 – Lung function, COPD and inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Cabre, T. Jove, J. Vizcaino, D. Montañes, J. Frigola, R. Sagarra (Reus, Spain). COPD, an inflammatory systemic disease. Inflammatory parameters in a group of COPD patients. Eur Respir J 2014; 44: Suppl. 58, 4766

Member's Comments

No comment yet.

Related content which might interest you: The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Features of systemic inflammation in patients with stable COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Local and systemic inflammation in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Metabolic syndrome in patients with COPD and their association with systemic inflammation Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Systemic inflammation and cardiovascular disease in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Systemic inflammation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Role of inflammatory biomarkers in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Endothelial dysfunction and systemic inflammation in different COPD phenotypes Source: International Congress 2014 – COPD physiopathology Year: 2014 Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort Source: International Congress 2015 – Multidimensional analysis of respiratory problems Year: 2015 Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015 Survivin in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype Source: International Congress 2016 – Monitoring comorbidities Year: 2016